| Biotech Sector News |
| BioSpace
Beat-daily compendium of news, plus archives |
| BIO
SmartBrief-sign up for the day's news delivered to your email inbox |
| Yahoo
Biotech Finance-press releases and news articles, updated throughout
the day |
| FDA
News-the source for regulatory news, but not always easy to use |
| FDA Advisory
Committee Meetings |
| Check
these sites for meeting dates. The day before an advisory committee meets,
briefing materials (including the FDA's analysis of the submission)
become available to public |
| CDER
Meetings-drugs |
| CBER-biologics |
| Patient
Resources |
| Center
Watch—our choice for the most extensive and detailed listing of
clinical trials for patients and professionals. Free |
| Cancer
Centers—List of all NCI-designated cancer treatment centers |
| CRAB-Cancer
Research and Biostatistics. An excellent compendium of government agency
links, clinical trial cooperative groups, and a host of useful resources |
| Patient
Advocacy Groups—listed by disease from the New York Biotechnology
Association |
| Government
Agencies |
| FDA
News—the source for regulatory news, but not always easy to use. |
| Cancer
Centers—List of all NCI-designated cancer treatment centers. |
| CRAB—Cancer
Research and Biostatistics. An excellent compendium of government agency
links, clinical trial cooperative groups, and a
host of useful resources. |
|
What Do People Say About MTSL?
'Please accept my thanks for providing the help that even those of us whose careers are in biotechnology require to navigate towards investment success. I look forward to future issues and to a long relationship with The Medical Technology Stock Letter.'
Arnold D. Gale, M.D., FAAP
| |
'After reading hundreds of financial newsletters every week for over 20 years, I can tell you that the Medical Technology Stock Letter is one of just a small handful of newsletters that I consider a must-read for all serious growth investors. In terms of knowledge, expertise and advice on biotechnology stocks, John McCamant is quite simply the very best in the business.'
Steven Halpern
Publisher and Editor of thestockadvisors
|
|
